Cosmo Pharmaceuticals NV
SIX:COPN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
IE |
|
T
|
Tencent Holdings Ltd
XMUN:NNN1
|
CN |
|
Banco Bilbao Vizcaya Argentaria SA
NYSE:BBVA
|
ES |
|
VSE Corp
NASDAQ:VSEC
|
US |
|
Brookside Energy Ltd
ASX:BRK
|
AU |
|
Vertiv Holdings Co
NYSE:VRT
|
US |
|
Philogen SpA
MIL:PHIL
|
IT |
|
E
|
Eutelsat Communications SA
XMUN:E3B
|
FR |
|
A
|
Apple Inc
XBER:APC
|
US |
|
Nexa Resources SA
NYSE:NEXA
|
LU |
|
Z
|
Zhejiang Huamei Holding Co Ltd
SZSE:000607
|
CN |
|
A
|
Ault Alliance Inc
AMEX:AULT
|
US |
|
C
|
China Satellite Communications Co Ltd
SSE:601698
|
CN |
|
OLB Group Inc
NASDAQ:OLB
|
US |
|
Haier Smart Home Co Ltd
SSE:600690
|
CN |
|
Posco Holdings Inc
KRX:005490
|
KR |
|
Woodside Petroleum Ltd
ASX:WPL
|
AU |
|
Unipol Gruppo SpA
MIL:UNI
|
IT |
|
Amkor Technology Inc
NASDAQ:AMKR
|
US |
|
T
|
Tupperware Brands Corp
SWB:TUP
|
US |
|
Lloyds Banking Group PLC
LSE:LLOY
|
UK |
|
C
|
Critical Metals Corp
NASDAQ:CRML
|
AU |
Bankruptcy Probability
Cosmo Pharmaceuticals NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cosmo Pharmaceuticals NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IE |
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
1.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
542.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
293.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
225.7B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
265.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
245.3B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cosmo Pharmaceuticals NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cosmo Pharmaceuticals NV has total debt of 3.6m EUR. This includes both short-term (0 EUR) and long-term (3.6m EUR) debt.
You can find a full breakdown on its Balance Sheet.
